SHALBY · Concall Summary
SHALBY LIMITED
Shalby Limited held its Q1 FY27 Earnings Conference Call on August 13, 2026, where management discussed the company's financial performance. Consolidated revenues increased to ₹338.6 crores, reflecting an 11.6% year-on-year growth. EBITDA rose to ₹49 crores, with a margin of 14.5%, down from 16% in the previous year. The consolidated PAT improved to ₹10.5 crores, with a PAT margin of 3.1%. The standalone hospital segment reported revenues of ₹259 crores, a 7% increase, but EBITDA margins declined to 18.4%. The Gurgaon unit achieved EBITDA break-even for the first time. The MedTech segment showed strong growth, with revenues up 53% year-on-year. Management expressed confidence in sustaining growth and improving profitability, particularly in the hospital segment, while addressing challenges in the MedTech business due to foreign exchange impacts. The call concluded with a Q&A session addressing various operational and financial queries.
Management highlighted both growth achievements and challenges in profitability.
View source filing →Earlier concalls
- 2026-08-12 — Shalby Limited submitted an investor presentation detailing its financial and operational performance for the quarter en…
- 2026-06-02 — Shalby Limited's earnings conference call on May 29, 2026, highlighted a strong financial performance for Q4 FY2026, wit…
- 2026-02-18 — Shalby Limited held its Q3 FY '26 earnings conference call on February 12, 2026, where management discussed the company'…
See SHALBY's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free